Alejandro Velez Arce
About Alejandro Velez Arce
Alejandro Velez Arce is an Equity Options Trading Analyst with a strong background in machine learning and robotics. He has held various roles at prestigious institutions, including Cruise and The World Bank, and is the co-founder and CEO of Alphunt, an AI-focused company.
Work at Group One Trading
Alejandro Velez Arce has been employed as an Equity Options Trading Analyst at Group One Trading, LP since 2017. He works remotely from Boston, Massachusetts, contributing to the firm's trading strategies and analysis in the equity options market. His role involves utilizing quantitative methods and data analysis to inform trading decisions.
Current Role at Cruise
Alejandro currently serves as a Senior ML / Robotics Software Engineer at Cruise, a position he has held since 2022. In this role, he applies his expertise in machine learning and robotics to develop advanced technologies for autonomous vehicles. His work is based in San Francisco, California.
Education and Expertise
Alejandro Velez Arce earned a Master's degree in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology (MIT) from 2018 to 2023. He also holds two Bachelor of Science degrees from MIT, one in Computer Science and Engineering and another in Management with a focus on Mathematical Economics, completed between 2013 and 2017. His educational background supports his extensive experience in machine learning, robotics, and data science.
Background in Research and Development
Alejandro has a significant background in research, having worked as an Undergraduate Research Assistant at MIT AeroAstro for a decade. He has also held positions at The World Bank as a Research Fellow, focusing on data science, visualization, and development economics since 2017. His experience includes roles at MIT's CSAIL and as a Teaching Assistant, contributing to various academic and research projects.
Entrepreneurial Ventures
In 2023, Alejandro co-founded Alphunt, an AI-first company dedicated to creating a discovery platform in molecular biology. As CEO, he leads the company's strategic direction and innovation efforts, leveraging his technical background and industry knowledge to advance the field.